January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreFebruary 18, 2026
According to our projections, the digital diagnostics system market was valued at USD 1.45 billion in 2025 and reached USD 1.71 billion in 2026, and it is projected to grow to USD 7.67 billion by 2035, expanding at a CAGR of 18.12% during 2026–2035....
February 17, 2026
The global cystic fibrosis therapeutics market expected to reach USD 44.72 billion by 2035, growing at a CAGR of 14.24% over the forecast period. In 2024, North America dominated the market, while Asia-Pacific is set for the fastest growth. CFTR modulators led by drug class, with pancreatic enzyme supplements projected for the highest CAGR. Oral ad...
February 17, 2026
According to market projections, the global bispecific antibody market, valued at USD 17.24 billion in 2025, is anticipated to reach USD 662.84 billion by 2035, growing at a CAGR of 44.04% over the next decade. The bispecific antibody market is expanding due to increasing occurrences of cancer as well as rising developments. North America led the m...
February 17, 2026
According to market projections, the subcutaneous biologics sector is expected to grow from USD 2.1 billion in 2025 to USD 6.01 billion by 2035, reflecting a CAGR of 11.09%. The growing demand for self-administration and the need for targeted therapy bolster the market. North America dominated the global market owing to its advanced healthcare infr...
February 17, 2026
According to our market projections, the global filtration in biologics market, valued at USD 8.44 billion in 2025, is anticipated to reach USD 29.01 billion by 2035, growing at a CAGR of 13.14% over the next decade. North America was dominant with a major share of the market, due to increasing growth in biologics and the enforcement of strict...
February 17, 2026
Market insights predict, the stem cell reconstructive industry is expected to grow from USD 1.88 billion in 2025 to USD 12.48 billion by 2035, driven by a CAGR of 20.81%. Growing cases of chronic diseases like heart conditions, diabetes, neurodegenerative disorders, and the demand for personalized medicine are driving the global market growth. Nort...
February 17, 2026
Market insights predict the global life sciences enterprise storage industry will increase from USD 2.86 billion in 2025 to USD 4.96 billion by 2035, achieving a CAGR of 5.65%. Widespread digitization of healthcare and research data around the world, with accelerating demand for customized therapies and analysis of large genomic datasets, is fuelin...
February 17, 2026
Our projections indicate that, the oncology clinical trial monitor market was valued at USD 15.76 billion in 2026 and is projected to reach USD 25.6 billion by 2035, expanding at a CAGR of 5.54% (2026–2035)....
February 17, 2026
According to our forecasts, the drug delivery CDMO market is set for strong growth from 2026 to 2035, driven by rising chronic diseases, expanding biologics and GLP-1 therapies, and increasing outsourcing by pharmaceutical and biotech companies....
February 17, 2026
Our projections indicate that, the cold pain therapy OTC products market was valued at USD 1.57 billion in 2025 and reached USD 1.65 billion in 2026, and is projected to grow to USD 2.57 billion by 2035, expanding at a CAGR of 5.04% during 2026–2035....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
